elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28972234-88803EAF-1895-45F9-8182-09F89845645B
Q28972234-88803EAF-1895-45F9-8182-09F89845645B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28972234-88803EAF-1895-45F9-8182-09F89845645B
Triple Reuptake Inhibitors: A Premise and Promise
P2860
Q28972234-88803EAF-1895-45F9-8182-09F89845645B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28972234-88803EAF-1895-45F9-8182-09F89845645B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
319ac7c07cd66db6838c393da5cf5e671d0986eb
P2860
Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.